FRAXODI 15 200 IU anti-Xa/0.8 ml, solution for injection (s.c.) in a pre-filled syringe 10 syringes of 0.8 ml
Active ingredients: Nadroparin calcium
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 syringes of 0.8 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- FRAXODI 15 200 UI anti-Xa/0,8 mL, solution injectable (S.C.) en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 10 seringue(s) préremplie(s) en verre de 0,8 ml avec système de sécurité
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Sept 1998
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68865128CIP73473331CIP133400934733314Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NADROPARINE CALCIQUEsolution | 15 200 UI anti-Xa · une seringue préremplie | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.